Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ambulance Finger-Prick test could spot worst injuries

NCT ID NCT06969404

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a simple finger-prick blood test for lactate, done in the ambulance, can help predict which patients with serious injuries from accidents or falls will have poor outcomes. Researchers will enroll 550 adults with potentially severe trauma and measure capillary lactate at the scene and again at the hospital. The goal is to see if this quick, risk-free test can improve how emergency teams decide where to send patients for the best care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give paramedics a simple, fast tool to better identify which trauma patients need the most urgent care.
What could go wrong
This is an early observational study, not a treatment trial. The test may not prove accurate enough to change current practice, and results may not apply to all trauma settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 550 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient over 18 years of age * Presenting a potentially serious pre-hospital trauma defined by: o A road accident or a fall of more than 2 metres * Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service) * And transferred to an emergency facility in the Alpes Maritimes with medical assistance. * Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately. * Pregnant women may also take part in the study without any risk to themselves or their child. Exclusion Criteria: * Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder) * Patients under legal protection (guardianship, curatorship) * Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Polytrauma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Multiple Trauma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Polytrauma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Antibes Hospital

    NOT_YET_RECRUITING

    Antibes, 06400, France

  • Cannes hospital

    NOT_YET_RECRUITING

    Cannes, 06000, France

  • Nice University Hospital

    RECRUITING

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.